Clinical significance of peripheral blood minimal residual disease detection at the eighth day of induction therapy in children with B-cell acute lymphoblastic leukemia

WEI Shengjie; DOU Liurui; LIU Wei; SHI Mingyue; XIAO Mengyu; LI Dan; NIU Xiaona; NIU Junwei; BAI Yanliang; SUN Kai

doi:10.7619/jcmp.20220480

Journal of Clinical Medicine in Practice > 2022 > 26(15): 114-119, 124. > DOI: 10.7619/jcmp.20220480

WEI Shengjie, DOU Liurui, LIU Wei, SHI Mingyue, XIAO Mengyu, LI Dan, NIU Xiaona, NIU Junwei, BAI Yanliang, SUN Kai. Clinical significance of peripheral blood minimal residual disease detection at the eighth day of induction therapy in children with B-cell acute lymphoblastic leukemia[J]. Journal of Clinical Medicine in Practice, 2022, 26(15): 114-119, 124. DOI: 10.7619/jcmp.20220480

Citation:

PDF (1814 KB)

Clinical significance of peripheral blood minimal residual disease detection at the eighth day of induction therapy in children with B-cell acute lymphoblastic leukemia

1.
People's Hospital of Zhengzhou University, Zhengzhou, Henan, 450003
2.
Department of Hematology and Oncology, Henan Children's Hospital, Zhengzhou, Henan, 450000
3.
Department of Hematology, Henan Provincial People's Hospital, Zhengzhou, Henan, 450003

More Information

Received Date: February 16, 2022
Available Online: August 22, 2022

Graphical Abstract

Abstract

Abstract

Objective
To analyze clinical significance of peripheral blood minimal residual disease (MRD) detection at the eighth day of induction therapy in evaluating prognosis of children with B-cell acute lymphoblastic leukemia (B-ALL) based on the TARGET database.
Methods
Data of 359 B-ALL children with peripheral blood MRD at the eighth day of induction therapy and bone marrow MRD at 29th day of induction therapy from year 2000 to 2010 were downloaded from TARGET database. Spearman correlation analysis was used to explore the association between peripheral blood MRD at the eighth day and morphology of bone marrow cells in the same period. Kaplan-Meier curve was used to analyze the relationship between peripheral blood MRD at the eighth day and event free survival (EFS), and further analyze the relationship of combined detection of peripheral blood MRD at the eighth day and bone marrow MRD at 29th day with EFS. Cox regression model was used to analyze the risk factors for prognosis in B-ALL children.
Results
Spearman correlation analysis showed that the level of peripheral blood MRD at the eighth day was positively correlated with the proportion of bone marrow blasts at day 8 (r=0.620, P < 0.001). Survival analysis showed that there were significant differences in 5-year EFS rates of MRD < 0.01%, 0.01% to 0.10%, 0.10% to 1.00% and ≥ 1.00% in peripheral blood at the eighth day(P < 0.001). Double-negative patients with peripheral blood MRD at the 8th day and bone marrow MRD at the 29th day had the best prognosis, followed by single-positive patients, and double-positive patients had the worst prognosis, the differences were statistically significant (P < 0.001). The combined MRD at both time points showed that the prognosis was best in the double-negative group, followed by the single-positive group and worst in the double-positive group (P < 0.001). In children with negative bone marrow MRD at day 29, the 5-year EFS rate of children negative for MRD in peripheral blood at the eighth day was significantly higher than those positive for MRD in peripheral blood at the eighth day(P=0.009). Cox regression analysis showed that MRD ≥ 0.10% in peripheral blood on day 8(HR=1.967; 95%CI, 1.234 to 3.134; P=0.004), MRD ≥ 0.01% in bone marrow on day 29 (HR=2.076; 95%CI, 1.423 to 3.027; P < 0.001) were independent risk factors for EFS in B-ALL children.
Conclusion
Peripheral blood MRD at day 8 of induction therapy has important clinical significance in prognosis assessment in children with B-ALL, and can be used as a strong supplement for the prognosis assessment of B-ALL children with bone marrow MRD at day 29.
- children,
- B-cell acute lymphoblastic leukemia,
- peripheral blood,
- minimal residual disease,
- event free survival,
- TARGET database

FullText(HTML)

References (23)

References

[1]	PUI C H, YANG J J, HUNGER S P, et al. Childhood acute lymphoblastic leukemia: progress through collaboration[J]. J Clin Oncol, 2015, 33(27): 2938-2948. doi: 10.1200/JCO.2014.59.1636
[2]	冯静, 陈晓娟, 刘晓明, 等. 多参数流式细胞术检测的微小残留病与儿童急性B淋巴细胞白血病预后的相关性研究[J]. 中华血液学杂志, 2019, 40(8): 678-680.
[3]	JABBOUR E, GÖKBUGET N, ADVANI A, et al. Impact of minimal residual disease status in patients with relapsed/refractory acute lymphoblastic leukemia treated with inotuzumab ozogamicin in the phase Ⅲ INO-VATE trial[J]. Leuk Res, 2020, 88: 106283. doi: 10.1016/j.leukres.2019.106283
[4]	丁超, 单建芝, 吕娅, 等. 急性淋巴细胞白血病微小残留病检测的方法、标本选择、临床意义研究进展[J]. 山东医药, 2019, 59(6): 103-106. doi: 10.3969/j.issn.1002-266X.2019.06.029
[5]	BROWN P, INABA H, ANNESLEY C, et al. Pediatric acute lymphoblastic leukemia, version 2.2020, NCCN clinical practice guidelines in oncology[J]. J Natl Compr Canc Netw, 2020, 18(1): 81-112. doi: 10.6004/jnccn.2020.0001
[6]	吕敏, 田国祥, 郭晓娟, 等. TARGET数据库的介绍及数据提取[J]. 中国循证心血管医学杂志, 2019, 11(4): 387-390. doi: 10.3969/j.issn.1674-4055.2019.04.02
[7]	中华医学会儿科学分会血液学组, 《中华儿科杂志》编辑委员会. 儿童急性淋巴细胞白血病诊疗建议(第四次修订)[J]. 中华儿科杂志, 2014, 52(9): 641-644. doi: 10.3760/cma.j.issn.0578-1310.2014.09.001
[8]	中华医学会儿科学分会血液学组, 中华儿科杂志编辑委员会. 儿童急性淋巴细胞白血病诊疗建议(第三次修订草案)[J]. 中华儿科杂志, 2006, 44(5): 392-395. doi: 10.3760/j.issn:0578-1310.2006.05.023
[9]	BOROWITZ M J, PULLEN D J, SHUSTER J J, et al. Minimal residual disease detection in childhood precursor-B-cell acute lymphoblastic leukemia: relation to other risk factors. A Children's Oncology Group study[J]. Leukemia, 2003, 17(8): 1566-1572. doi: 10.1038/sj.leu.2403001
[10]	BOROWITZ M J, DEVIDAS M, HUNGER S P, et al. Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study[J]. Blood, 2008, 111(12): 5477-5485. doi: 10.1182/blood-2008-01-132837
[11]	MAO R, HU S X, ZHANG Y C, et al. Prognostic nomogram for childhood acute lymphoblastic leukemia: a comprehensive analysis of 673 patients[J]. Front Oncol, 2020, 10: 1673. doi: 10.3389/fonc.2020.01673
[12]	VAN DER VELDEN V H J, JACOBS D C H, WIJKHUIJS A J M, et al. Minimal residual disease levels in bone marrow and peripheral blood are comparable in children with T cell acute lymphoblastic leukemia (ALL), but not in precursor-B-ALL[J]. Leukemia, 2002, 16(8): 1432-1436. doi: 10.1038/sj.leu.2402636
[13]	COUSTAN-SMITH E, SANCHO J, HANCOCK M L, et al. Use of peripheral blood instead of bone marrow to monitor residual disease in children with acute lymphoblastic leukemia[J]. Blood, 2002, 100(7): 2399-2402. doi: 10.1182/blood-2002-04-1130
[14]	葛丽卫, 王笑颜. 流式细胞术用于白血病外周血细胞检测对急性白血病复发判断的意义[J]. 检验医学, 2018, 33(3): 239-241. doi: 10.3969/j.issn.1673-8640.2018.03.012
[15]	程丽萍, 张莉. 家长认知行为干预在提高白血病患儿治疗依从性中的应用研究[J]. 实用临床医药杂志, 2017, 21(16): 214-216. doi: 10.7619/jcmp.201716076
[16]	WOOD B, WU D, CROSSLEY B, et al. Measurable residual disease detection by high-throughput sequencing improves risk stratification for pediatric B-ALL[J]. Blood, 2018, 131(12): 1350-1359. doi: 10.1182/blood-2017-09-806521
[17]	MUFFLY L, SUNDARAM V, CHEN C, et al. Concordance of peripheral blood and bone marrow measurable residual disease in adult acute lymphoblastic leukemia[J]. Blood Adv, 2021, 5(16): 3147-3151. doi: 10.1182/bloodadvances.2021004234
[18]	BARTRAM J, WRIGHT G, ADAMS S, et al. High-throughput sequencing of peripheral blood for minimal residual disease monitoring in childhood precursor B-cell acute lymphoblastic leukemia: a prospective feasibility study[J]. Pediatr Blood Cancer, 2022, 69(3): e29513.
[19]	李红, 邵静波, 朱嘉莳, 等. 儿童急性淋巴细胞白血病早期治疗反应对预后的预测价值[J]. 临床儿科杂志, 2021, 39(8): 600-604. doi: 10.3969/j.issn.1000-3606.2021.08.010
[20]	安粉艳, 张淑红, 孔令军, 等. 微量残留病在儿童B系急性淋巴细胞白血病危险分层及预后中的临床意义[J]. 中国实验血液学杂志, 2017, 25(3): 729-735.
[21]	PIETERS R, DE GROOT-KRUSEMAN H, VAN DER VELDEN V, et al. Successful therapy reduction and intensification for childhood acute lymphoblastic leukemia based on minimal residual disease monitoring: study ALL10 from the Dutch childhood oncology group[J]. J Clin Oncol, 2016, 34(22): 2591-2601. doi: 10.1200/JCO.2015.64.6364
[22]	薛玉娟, 陆爱东, 王毓, 等. 微小残留病在儿童急性B淋巴细胞白血病预后中的意义[J]. 临床儿科杂志, 2021, 39(5): 321-326. doi: 10.3969/j.issn.1000-3606.2021.05.001
[23]	O'CONNOR D, MOORMAN A V, WADE R, et al. Use of minimal residual disease assessment to redefine induction failure in pediatric acute lymphoblastic leukemia[J]. J Clin Oncol, 2017, 35(6): 660-667. doi: 10.1200/JCO.2016.69.6278

[1]	LIU Dan, YANG Mingzhu, ZHANG Jiaorui. Levels of serum solute carrier family 7 member 11 and platelet-derived growth factor BB in children with bronchial asthma and their correlations with disease severity[J]. Journal of Clinical Medicine in Practice, 2025, 29(6): 39-44. DOI: 10.7619/jcmp.20244177
[2]	SHAO Zhongxin, LI Shiying. Effect of propofol regulating macrophage polarization on airway inflammatory response and Toll-like receptor 4-NOD-like receptor protein 3 pathway in mice with bronchial asthma[J]. Journal of Clinical Medicine in Practice, 2025, 29(6): 13-19. DOI: 10.7619/jcmp.20245587
[3]	ZHANG Pan, WEI Yuanyuan, WANG Hao, WANG Xianwei, LI Yanqing, SUN Xue. Effect of Callicarpa nudiflora on wound healing and PI3K/AKT/mTOR pathway by regulating M2 macrophage polarization in rats with diabetic foot ulcer[J]. Journal of Clinical Medicine in Practice, 2025, 29(4): 44-49, 54. DOI: 10.7619/jcmp.20243269
[4]	MA Jiao, HUO Jingyu, HAN Caiyun. Correlations of serum dual-specific phosphatase 1 and soluble cluster of differentiation 93 with severity of disease, lung function and airway inflammation in children with acute-phase bronchial asthma[J]. Journal of Clinical Medicine in Practice, 2025, 29(3): 118-122. DOI: 10.7619/jcmp.20242394
[5]	WU Lili, LIN Jingtao, ZHANG Yuancheng, ZHONG Peimin, TANG Jinsong, WANG Haibo. Mechanisms of mesenchymal stem cell-derived extracellular vesicles in improvement of renal injury in rats with diabetic nephropathy by regulating mammalian target of rapamycin/p70 ribosome protein S6 kinase/coiled-coil myosin-like Bcl-2-interacting protein pathway[J]. Journal of Clinical Medicine in Practice, 2024, 28(10): 51-57. DOI: 10.7619/jcmp.20232784
[6]	WANG Haitong, LIU Jianliang. Mechanism of naringin on retinal microvascular endothelial cells injury based on adenosine-monophosphate-activated protein kinase/mammalian target of rapamycin pathway[J]. Journal of Clinical Medicine in Practice, 2024, 28(3): 23-28. DOI: 10.7619/jcmp.20233233
[7]	HU Xiaolin, HAO Xin, LI Wenqian, ZHAO Tiantian, HOU Sicong. SLC1A5 combined with TM4SF1 regulates the migration of esophageal squamous cell through mTOR signaling pathway[J]. Journal of Clinical Medicine in Practice, 2023, 27(14): 45. DOI: 10.7619/jcmp.20230772
[8]	YI Jinling, Tubikezi·YIBILI, Gulihumaer·AINIWAER, LA Xiaolin. Effect of TAM family receptor tyrosine kinases on signaling pathway of mammalian target of rapamycin in patients with endometriosis[J]. Journal of Clinical Medicine in Practice, 2023, 27(2): 7-12, 16. DOI: 10.7619/jcmp.20223087
[9]	GAO Li, LI Xiaoming, YANG Bo, QIN Ying, CHENG Dong, ZHENG Lifei, LI Li. Long non-coding RNA CBR3-AS1 mediates the mechanism of cytarabine resistance in leukemia cells through the PI3K/AKT/mTOR/S6K pathway[J]. Journal of Clinical Medicine in Practice, 2022, 26(8): 66-70, 75. DOI: 10.7619/jcmp.20214581
[10]	LI Yilong, LEI Kai, ZHANG Xiaozhao, DING Jingjian, ZHANG Shengtao, QIAO Wei, GUO Yongfeng. Study in effects of 1, 25-dihydroxyvitamin D₃ on apoptosis and autophagy of colon cancer cells and its mechanism[J]. Journal of Clinical Medicine in Practice, 2021, 25(13): 5-9. DOI: 10.7619/jcmp.20211388

Cited By

Cited by

Periodical cited type(1)

吴杨. 罗氟司特联合布地奈德对支气管哮喘患者肺功能小气道参数的影响. 中国药物与临床. 2025(03): 192-196 .

Other cited types(2)

Get Citation

PDF

XML

Article views (182) PDF downloads (14) Cited by(3)

Turn off MathJax

Article Contents

Abstract

References

Clinical significance of peripheral blood minimal residual disease detection at the eighth day of induction therapy in children with B-cell acute lymphoblastic leukemia